When to switch biologics: some answers, but lots of questions too

Br J Dermatol. 2018 Jan;178(1):20. doi: 10.1111/bjd.16118.

Authors

J Albrecht^{1

2}, S Gerdes³

Affiliations

¹ Division of Dermatology, Department of Medicine, J.H. Stroger Hospital of Cook County, Chicago, IL, U.S.A.
² Department of Dermatology, Rush Medical College, Chicago, IL, U.S.A.
³ Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.

PMID: 29357593
DOI: 10.1111/bjd.16118

No abstract available

Publication types

Comment

MeSH terms

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biological Products*
Double-Blind Method
Humans
Psoriasis
Ustekinumab*

Substances

Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Biological Products
guselkumab
Ustekinumab